Author:
Dalmizrak Aysegul,Dalmizrak Ozlem
Publisher
Springer International Publishing
Reference247 articles.
1. Abedi E, Ramzi M, Karimi M, Yaghobi R, Mohammadi H, Bayat E, Moghadam M, Farokhian F, Dehghani M, Golafshan HA, Haghpanah S (2021) TET2, DNMT3A, IDH1, and JAK2 mutation in myeloproliferative neoplasms in Southern Iran. Int J Organ Transplant Med 12(3):12–20
2. Agger K, Cloos PA, Rudkjaer L, Williams K, Andersen G, Christensen J, Helin K (2009) The H3K27me3 demethylase JMJD3 contributes to the activation of the INK4A-ARF locus in response to oncogene- and stress-induced senescence. Genes Dev 23(10):1171–1176. https://doi.org/10.1101/gad.510809
3. Akiki S, Dyer SA, Grimwade D, Ivey A, Abou-Zeid N, Borrow J, Jeffries S, Caddick J, Newell H, Begum S, Tawana K, Mason J, Velangi M, Griffiths M (2013) NUP98-NSD1 fusion in association with FLT3-ITD mutation identifies a prognostically relevant subgroup of pediatric acute myeloid leukemia patients suitable for monitoring by real time quantitative PCR. Genes Chromosomes Cancer 52(11):1053–1064. https://doi.org/10.1002/gcc.22100
4. Allis CD, Jenuwein T (2016) The molecular hallmarks of epigenetic control. Nat Rev Genet 17(8):487–500. https://doi.org/10.1038/nrg.2016.59
5. Aref S, Sallam N, Abd Elaziz S, Salama O, Al Ashwah S, Ayed M (2022) Clinical implication of DNMT3A and TET2 genes mutations in cytogenetically normal acute myeloid leukemia. Asian Pac J Cancer Prev 23(12):4299–4305. https://doi.org/10.31557/APJCP.2022.23.12.4299